Skip to main content
WLYBJohn Wiley & Sons, Inc.Sell5.3·$48.00-0.79%
WLYB · Concentration risk · 10-K extracted

John Wiley & Sons (WLYB) concentration risks

Updated

The most significant concentration John Wiley & Sons discloses is Research at 64%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: John Wiley & Sons’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH1
MEDIUM2
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
64%

Research

10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025, with a 32.1% Adjusted EBITDA margin.'
SEC 10-K · filed Jun 2025
MEDIUMBuilt-inGeographic
49%

outside the US

10-K Item 1: 'In the year ended April 30, 2025, approximately 49% of our consolidated revenue was from outside the US.'
SEC 10-K · filed Jun 2025
MEDIUMOutside partyCounterparty
46%

professional societies and publishing partners

10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners such as research institutions or foundations'
SEC 10-K · filed Jun 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-09-06

Wiley's concentration risk centers on its core business line, with meaningful geographic and partner-based exposures layered on top. Research revenue accounted for approximately 64% of consolidated revenue in the year ended April 30, 2025, a high-share structural concentration that makes the Research segment's performance the primary determinant of overall results. Geographically, approximately 49% of consolidated revenue came from outside the U.S. in the same year, a medium-share structural exposure tying nearly half the business to international markets, currency, and regulatory conditions. Within Journal Subscriptions specifically, approximately 46% of revenue is derived from publication rights owned by professional societies and other publishing partners such as research institutions or foundations — a medium-share dependency on third parties who control the underlying content rights rather than Wiley itself. None of the three exposures names a single dominant counterparty; the risk is concentrated in a business line, a broad international revenue base, and a class of rights-holding partners. The publishing-partner dependency is the one line where a shift in society relationships, rather than a market or macro shock, could move the verdict.

For the engine’s reasoning on WLYB’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Publishing

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
WLYJohn Wiley & Sons, Inc.1203
WLYBJohn Wiley & Sons, Inc.1203
TDAYUSA TODAY Co., Inc.1102
NYTNew York Times Company (The)0101
SCHLScholastic Corporation0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks WLYB Concentration risk